Evidence map›Paper›PMID 32791893›Full record

ArticleThe American journal of psychiatry2020

An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression.

Karmel W Choi, Murray B Stein, Kristen M Nishimi, Tian Ge, Jonathan R I Coleman, Chia-Yen Chen, Andrew Ratanatharathorn, Amanda B Zheutlin, Erin C Dunn, 23andMe Research Team and 4 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 4 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 4 syntheses or guidelines pooled it, 227 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Exposome factors predict the association between sleep health and depression.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Time to Address Eating Disorder Risk Among Medical Students.Behavioral sciences (Basel, Switzerland) · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Karmel W ChoiDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Murray B SteinDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Kristen M NishimiDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Tian GeDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Jonathan R I ColemanDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Chia-Yen ChenDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Andrew RatanatharathornDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Amanda B ZheutlinDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Erin C DunnDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
23andMe Research TeamDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Major Depressive Disorder Working Group of the Psychiatric Genomics ConsortiumDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Gerome BreenDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Karestan C KoenenDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Jordan W SmollerDepartment of Psychiatry, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston (Choi, Chen, Zheutlin, Dunn, Koenen, Smoller); Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston (Choi, Nishimi, Koenen, Smoller); Biogen, Cambridge, Mass. (Chen); Departments of Psychiatry and Family Medicine and Public Health, University of California, San Diego, La Jolla (Stein); Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Coleman, Breen); and Department of Epidemiology, Columbia University Mailman School of Public Health, New York (Ratanatharathorn).
Massachusetts General Hospital · US

Funding

Training Program in Psychiatric Genetics and Translational ResearchT32MH017119 · NIMH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KARESTAN C KOENEN, Jukka-Pekka Onnela · 1985 to 2026
$8.9M
Exploring the genetic basis of AD progressionK99AG054573 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GE, TIAN · 2017 to 2018
$274k
NIA NIH HHS K99 AG054573NIMH NIH HHS T32 MH017119
6 · The paper itself

Abstract

objectiveEfforts to prevent depression, the leading cause of disability worldwide, have focused on a limited number of candidate factors. Using phenotypic and genomic data from over 100,000 UK Biobank participants, the authors sought to systematically screen and validate a wide range of potential modifiable factors for depression.

methodsBaseline data were extracted for 106 modifiable factors, including lifestyle (e.g., exercise, sleep, media, diet), social (e.g., support, engagement), and environmental (e.g., green space, pollution) variables. Incident depression was defined as minimal depressive symptoms at baseline and clinically significant depression at follow-up. At-risk individuals for incident depression were identified by polygenic risk scores or by reported traumatic life events. An exposure-wide association scan was conducted to identify factors associated with incident depression in the full sample and among at-risk individuals. Two-sample Mendelian randomization was then used to validate potentially causal relationships between identified factors and depression.

resultsNumerous factors across social, sleep, media, dietary, and exercise-related domains were prospectively associated with depression, even among at-risk individuals. However, only a subset of factors was supported by Mendelian randomization evidence, including confiding in others (odds ratio=0.76, 95% CI=0.67, 0.86), television watching time (odds ratio=1.09, 95% CI=1.05, 1.13), and daytime napping (odds ratio=1.34, 95% CI=1.17, 1.53).

conclusionsUsing a two-stage approach, this study validates several actionable targets for preventing depression. It also demonstrates that not all factors associated with depression in observational research may translate into robust targets for prevention. A large-scale exposure-wide approach combined with genetically informed methods for causal inference may help prioritize strategies for multimodal prevention in psychiatry.

Indexed as

AdultDatabases as TopicDepressionDietExerciseFemaleHumansMaleMendelian Randomization AnalysisMultifactorial InheritanceRisk FactorsScreen TimeSleep HygieneDepressionExposomeMendelian RandomizationPolygenic RiskPreventionProtective Factors

Identifiers

PMID32791893
PMCPMC9361193
OpenAlexW3049025822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.